amlashbispecificsbloodcancerscarecellchicagoclinicalcllcmlcontroversiescostdahiyadatadiscussdiscussesdiseasedlbcldrseditorendpointsevolutionfellowsfollicularfrontlinefuturehighhighlightshodgkininnovationsinsidelatestlivelymphomamalignanciesmanagementmbbsmdmdsmmmphmpnmrdmyelomanewsnextnhlquestionquestionsrealrevolutionrisksaysshadmansohospecialspiegeltellstherapiestherapytimetreatingtreatmenttrialsunansweredupdatesususmanivenugopalworld